1. Biopharma execs address the challenges of a post-pandemic workplace — Bristol Myers pays $200M upfront plus $1.36B in biobucks for Agenus' preclinical TIGIT asset — Novo Nordisk nets Ph2 win for former Corvidia kidney programSee more on our front page news
    Dismiss Notice

Create Thread

Anonymous Board for Philips Pathology

Verification:

(CustomImgCaptcha By Surrey Forum)

Tags:

Multiple tags may be separated by commas.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.

Options: